Compare RGEN & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space and cyber domains. The company is in the design, development and manufacture of Advanced sensing, network computing, force protection and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue and Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designs, develops and manufactures sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision making and execution by the customers.